The paper: A April 2026 review in Frontiers in Aging maps nine therapeutic peptides onto the hallmarks of aging — tirzepatide, Epitalon, GHK-Cu, BPC-157, TB-500, Semax, CJC-1295, Ipamorelin and bremelanotide/PT-141. The authors carefully separate the FDA-approved agents (tirzepatide, bremelanotide), which have robust safety data, from the investigational peptides, which they say still need rigorous clinical validation. It is a mechanisms-and-evidence map, not a treatment recommendation.
Primary source (peer-reviewed, open access): Mavrych V, Shypilova I, Bolgova O. “Therapeutic peptides in gerontology: mechanisms and applications for healthy aging.” Frontiers in Aging, 2026;7. doi:10.3389/fragi.2026.1790247. We summarise; read the original for the full review.
Peptides and “longevity” get thrown together in a lot of marketing. It is genuinely useful, then, when a peer-reviewed journal steps back and organises the field by mechanism — which is exactly what this 2026 Frontiers in Aging review does. It takes nine of the most-discussed peptides and maps each onto a recognised hallmark of aging, while being clear-eyed about how much (or how little) human evidence stands behind each one.
Here is the framework the authors lay out, paraphrased for plain reading. Where we have a deeper explainer, the compound links through.
| Mechanism / hallmark | Peptide(s) | Status noted |
|---|---|---|
| Metabolic regulation (GIP/GLP-1) | Tirzepatide | FDA-approved |
| Telomere biology (telomerase) | Epitalon | Investigational |
| Dermal regeneration (copper tripeptide) | GHK-Cu | Investigational |
| Tissue repair / angiogenesis | BPC-157, TB-500 | Investigational |
| Neuroprotection (BDNF, ACTH analog) | Semax | Investigational |
| Growth-hormone axis | CJC-1295, Ipamorelin | Investigational |
| Sexual function (melanocortin) | Bremelanotide / PT-141 | FDA-approved |
The most useful thing in the review is not the list — it is the discipline. The authors explicitly separate the two FDA-approved agents in the set (tirzepatide and bremelanotide), which carry robust clinical safety data, from the rest, which they describe as investigational and in need of “rigorous validation through well-designed clinical trials.” That mirrors what we have written across our own compound explainers: approval is a high, specific bar, and most peptides have not cleared it. See which peptides are FDA approved for the same distinction applied product-by-product.
For the non-approved compounds, the review highlights significant knowledge gaps — long-term safety, optimal dosing, and how peptides behave in combination are all called out as unresolved. This is the responsible reading of the field in 2026: real mechanistic interest, real preclinical signal, and a genuine evidence gap that only proper trials can close. It is also why the honest framing for these compounds remains research use only, not for human consumption.
Why this matters for readers. A peer-reviewed mechanism map is a far better starting point than a seller’s claims. If a compound is described as “investigational” in the literature, treat “miracle anti-aging” marketing around it with appropriate scepticism.
What did the 2026 review find?
It mapped nine peptides onto aging hallmarks and separated FDA-approved agents (tirzepatide, bremelanotide) from investigational compounds needing clinical validation.
Which peptides are covered?
Tirzepatide, Epitalon, GHK-Cu, BPC-157, TB-500, Semax, CJC-1295, Ipamorelin and bremelanotide/PT-141.
Is it a recommendation to take them?
No. It is an academic review of mechanisms and evidence, explicitly flagging knowledge gaps for the non-approved compounds.
Primary source: Mavrych V, Shypilova I, Bolgova O, “Therapeutic peptides in gerontology: mechanisms and applications for healthy aging,” Frontiers in Aging 2026;7, doi:10.3389/fragi.2026.1790247. External links are provided for research reference only; New-U is not affiliated with these organisations and links carry no endorsement either way.
New-U Research Compounds supplies sealed 10-vial packs, independently verified by Janoshik and Freedom Diagnostics for >99% purity, with a Certificate of Analysis. Research use only - not for human consumption.
Browse the catalogAt New-U, we believe better conversations start with better information. For laboratory research use only. Not for human consumption.